Citius Oncology, Inc.
CTOR
$1.13
$0.010.89%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 3,924,800.00% | 0.00% | 0.00% | 0.00% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 29.51% | 12.19% | 6.66% | 73.92% | -- |
| Prepaid Expenses | 21.03% | -59.26% | 0.00% | 0.00% | -73.02% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 50.43% | 1.50% | 5.61% | 55.73% | 9.61% |
|
|
|||||
| Total Current Assets | 50.43% | 1.50% | 5.61% | 55.73% | 9.61% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | 0.00% | 0.00% | 0.00% | 83.50% |
| Total Assets | 10.07% | 0.29% | 1.06% | 7.25% | 68.71% |
|
|
|||||
| Total Accounts Payable | 52.70% | 12.91% | 30.67% | 58.28% | -- |
| Total Accrued Expenses | -14.55% | 16.53% | 49.74% | 1,449.75% | -98.12% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -20.25% | 0.00% | 0.00% | 0.00% | -- |
| Total Other Current Liabilities | -20.25% | 0.00% | 0.00% | 0.00% | -- |
| Total Current Liabilities | -6.60% | 6.53% | 14.61% | 32.72% | 4.17% |
|
|
|||||
| Total Current Liabilities | -6.60% | 6.53% | 14.61% | 32.72% | 4.17% |
| Long-Term Debt | 0.00% | 0.00% | 0.00% | 0.00% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.49% | 11.71% | 13.27% | 15.29% | 9.09% |
| Total Liabilities | -5.45% | 6.30% | 13.43% | 28.68% | 15.93% |
|
|
|||||
| Common Stock & APIC | 19.10% | 2.38% | 2.39% | 2.12% | 72.58% |
| Retained Earnings | -8.46% | -10.00% | -16.84% | -16.95% | -20.99% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 38.48% | -9.10% | -13.68% | -10.51% | 170.92% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 38.48% | -9.10% | -13.68% | -10.51% | 170.92% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 38.48% | -9.10% | -13.68% | -10.51% | 170.92% |
|
|
|||||